Quiescence in melanoma is not a rare and static state but a dynamic and reversible condition accessible to most tumor cells, ...

Researchers at the VIB-KU Leuven Center for Cancer Biology have uncovered that "natural killer" cells (NK), a type of immune ...

Researchers at the VIB-KU Leuven Center for Cancer Biology have uncovered that 'natural killer' cells (NK), a type of immune ...

Teva’s experimental anti-PD1-IL2 ATTENUKINE therapy is designed to selectively deliver interleukin-2 to PD-1-expressing T ...

This Research Topic explores the crucial role of stem cell–niche interactions in skin regeneration, homeostasis, and cancer. Skin stem cells, and ...

UPMC Hillman Cancer Center  physician scientist and melanoma researcher Yana Najjar, M.D. is the 2025 recipient of the Sy ...

Cancer Research UK, The University of Manchester and The Christie NHS Foundation Trust today [June 18] announced the ...